Raymond James Financial
ADAP

Raymond James Financial’s Adaptimmune Therapeutics ADAP Stock Holding History

Raymond James Financial’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$6.06K Hold
25,261
– – ﹤0.01% 6021
2025
Q1 		$4.98K Sell
25,261
-5,820
-19% -$1.15K ﹤0.01% 4732
2024
Q4 		$16.7K Buy
+31,081
New +$16.7K ﹤0.01% 4683